- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 265/32 - 1,4-OxazinesHydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms
Patent holdings for IPC class C07D 265/32
Total number of patents in this class: 164
10-year publication summary
|
13
|
8
|
5
|
5
|
10
|
1
|
9
|
9
|
9
|
4
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| California Institute of Technology | 3999 |
7 |
| Supernus Pharmaceuticals, Inc. | 134 |
7 |
| Sandoz AG | 1411 |
5 |
| Amgen Inc. | 4256 |
5 |
| Massachusetts Institute of Technology | 10150 |
4 |
| Gen1e Lifesciences Inc. | 29 |
4 |
| Apotex Pharmachem Inc. | 25 |
3 |
| Schering Corporation | 413 |
3 |
| TriStar Global Energy Solutions, Inc. | 30 |
3 |
| Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd. | 32 |
3 |
| Cr3 Zymeflow, Inc. | 30 |
3 |
| Zymeflow, Inc. | 42 |
3 |
| Glaxo Group Limited | 4145 |
2 |
| Glaxosmithkline LLC | 535 |
2 |
| 3m Innovative Properties Company | 17719 |
2 |
| BASF SE | 21098 |
2 |
| The Regents of the University of California | 20303 |
2 |
| Merck Sharp & Dohme Corp. | 2189 |
2 |
| Agency for Science, Technology and Research | 3646 |
2 |
| Chengdu Di'ao Pharmaceutical Group Co., Ltd. | 22 |
2 |
| Other owners | 98 |